Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 563-569 , December 2009

Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory

  • Fréderic Duprez

      Affiliations

    • Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium
    • Corresponding Author InformationCorresponding author. Address: Department of Radiotherapy, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium.
    • ,
  • Indira Madani

      Affiliations

    • Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium
    • ,
  • Katrien Bonte

      Affiliations

    • Department of Head and Neck Surgery, Ghent University Hospital, Ghent, Belgium
    • ,
  • Tom Boterberg

      Affiliations

    • Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium
    • ,
  • Luc Vakaet

      Affiliations

    • Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium
    • ,
  • Cristina Derie

      Affiliations

    • Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium
    • ,
  • Werner De Gersem

      Affiliations

    • Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium
    • ,
  • Wilfried De Neve

      Affiliations

    • Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium

Received 29 January 2009 ,Revised 13 October 2009 ,Accepted 22 October 2009.

References 

  1. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–2098
  2. Lefebvre JL, Rolland F, Tesselaar M, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst. 2009;101:142–152
  3. Pernot M, Malissard L, Hoffstetter S, et al. The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys. 1994;29:673–679
  4. Schwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994;74:1933–1938
  5. Goodwin WJ. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?. Laryngoscope. 2000;110:1–18
  6. Agra IM, Carvalho AL, Ulbrich FS, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck. 2006;28:107–113
  7. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med. 2001;345:1890–1900
  8. Browman GP, Cronin L. Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials. Semin Oncol. 1994;21:311–319
  9. Dawson LA, Myers LL, Bradford CR, et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:377–385
  10. Li JC, Hu CS, Jiang GL, et al. Dose escalation of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma: a prospective randomised study. Clin Oncol (R Coll Radiol). 2006;18:293–299
  11. Kasperts N, Slotman BJ, Leemans CR, de Bree R, Doornaert P, Langendijk JA. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma. Cancer. 2006;106:1536–1547
  12. Langendijk JA, Kasperts N, Leemans CR, Doornaert P, Slotman BJ. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol. 2006;78:306–312
  13. Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol. 2008;9:367–375
  14. Chen YJ, Kuo JV, Ramsinghani NS, Al-Ghazi MS. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer. Med Dosim. 2002;27:171–176
  15. Lu TX, Mai WY, Teh BS, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:682–687
  16. De Neve W, De Gersem W, Derycke S, et al. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control. Radiother Oncol. 1999;50:301–314
  17. Claus F, De Gersem W, De Wagter C, et al. An implementation strategy for IMRT of ethmoid sinus cancer with bilateral sparing of the optic pathways. Int J Radiat Oncol Biol Phys. 2001;51:318–331
  18. Madani I, Bonte K, Vakaet L, Boterberg T, De Neve W. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys. 2009;73:424–432
  19. Madani I, Vakaet L, Bonte K, Boterberg T, De Neve W. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys. 2008;71:1158–1166
  20. Wijers OB, Levendag PC, Tan T, et al. A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol. 1999;52:35–42
  21. Gregoire V, Coche E, Cosnard G, Hamoir M, Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol. 2000;56:135–150
  22. Ang KK, Jiang GL, Feng Y, Stephens LC, Tucker SL, Price RE. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys. 2001;50:1013–1020
  23. Claus F, De Gersem W, Vanhoutte I, et al. Evaluation of a leaf position optimization tool for intensity modulated radiation therapy of head and neck cancer. Radiother Oncol. 2001;61:281–286
  24. De Gersem W, Claus F, De Wagter C, De Neve W. An anatomy-based beam segmentation tool for intensity-modulated radiation therapy and its application to head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:849–859
  25. De Gersem W, Claus F, De Wagter C, Van Duyse B, De Neve W. Leaf position optimization for step-and-shoot IMRT. Int J Radiat Oncol Biol Phys. 2001;51:1371–1388
  26. De Neve W, De Gersem W, De Meerleer G. In response to Drs. Vaarkamp and Krasin. Int J Radiat Oncol Biol Phys. 2001;49:1519–1520
  27. Sherouse GW, Thorn J, Novins K. A portable 3D radiotherapy design system. Med Phys. 1989;16:466
  28. Available from: http://ctep.info.nih.gov/reporting/ctc.html [accessed 12.06.09].
  29. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys. 1995;31:1049–1091
  30. Claus F, Duthoy W, Boterberg T, et al. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience. Oral Oncol. 2002;38:597–604
  31. Lee N, Chan K, Bekelman JE, et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:731–740
  32. Langendijk JA, Bourhis J. Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr Opin Oncol. 2007;19:202–209
  33. Nagar YS, Singh S, Datta NR. Chemo-reirradiation in persistent/recurrent head and neck cancers. Jpn J Clin Oncol. 2004;34:61–68
  34. Salama JK, Vokes EE, Chmura SJ, et al. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2006;64:382–391
  35. Sulman EP, Schwartz DL, Le TT, et al. Imrt reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys. 2009;73:399–409
  36. Hehr T, Classen J, Belka C, et al. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial. Int J Radiat Oncol Biol Phys. 2005;61:1423–1431
  37. Vermorken J, Mesia R, Vega V. Cetuximab extends survival of patients with recurrent or metastatic SCCHN when added to first line platinum based therapy: results of a randomized phase III (EXTREME) study. J Clin Oncol. 2007;25:[Abstract 6091]
  38. Janot F, de Raucourt D, Benhamou E, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol. 2008;26:5518–5523
  39. Biagioli MC, Harvey M, Roman E, et al. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69:1067–1073
  40. Levendag PC, Teguh DN, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol. 2007;85:64–73

☆ Presented in part at the 2nd International Conference on Innovative Approaches in Head & Neck Oncology, Barcelona, Spain, 2009.

PII: S0167-8140(09)00606-9

doi: 10.1016/j.radonc.2009.10.012

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 563-569 , December 2009

Article Tools

* Image Usage & Resolution